TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
Bacon JVW, Giannatempo P, Cataldo G, Fazli L, Saxena N, Ozgun G, Soleimani M, Chi K, Nichols C, Necchi A, Wyatt AW, Kollmannsberger CK, Nappi L.
Bacon JVW, et al. Among authors: ozgun g.
Oncologist. 2022 Nov 3;27(11):e912-e915. doi: 10.1093/oncolo/oyac197.
Oncologist. 2022.
PMID: 36166584
Free PMC article.